Cash Flow | Aarti Drugs Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY11729.60  -159.80 (-1.34%)
SENSEX39922.46  -599.64 (-1.48%)
  • top gainers
  • top losers
  • top volume
  • top value
investments Associate Login Online Trading Login
  • indian indices
  • global indices

We are investment service provider for Buy stocks , Low Stocks Brokerage , Stocks Portfolio Management in Surat , NRI Investment in Stocks , Share Broking Surat , Stock Broking Surat , Advisory Services Surat and Competetive Stocks Brokerage. investment advisory, financial integrity and prompt services in the whole of South Gujarat.

L
equity
Home Markets & NewsCompany ProfileCash Flow

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE642.10-33.7 (-4.99 %)
PREV CLOSE (Rs.) 675.80
OPEN PRICE (Rs.) 655.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 78729
TODAY'S LOW / HIGH (Rs.)642.05 676.90
52 WK LOW / HIGH (Rs.)105.56 1025
NSE643.35-33.85 (-5 %)
PREV CLOSE( Rs. ) 677.20
OPEN PRICE (Rs.) 656.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 643.35 (9752)
VOLUME 1903443
TODAY'S LOW / HIGH(Rs.) 643.35 677.00
52 WK LOW / HIGH (Rs.)105.25 1026.95

Cash Flow

Select year
ParticularsMar2020Mar2019Mar2018Mar2017Mar2016
Profit Before Tax1852.891310.231245.031160.12952.75
Adjustment868.38752.03751.24716.29793.04
Changes In working Capital194.93-334.90-1051.9184.74-212.50
Cash Flow after changes in Working Capital2916.191727.36944.361961.141533.29
Cash Flow from Operating Activities2507.441430.92697.661747.551332.94
Cash Flow from Investing Activities-332.09-616.71-735.36-1069.76-987.95
Cash Flow from Financing Activities-2154.07-800.7039.17-682.29-332.59
Net Cash Inflow / Outflow21.2813.511.47-4.5012.41
Opening Cash & Cash Equivalents46.4432.9331.4635.9635.80
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent67.7146.4432.9331.4648.21
ATTENTION INVESTORS|KYC|IPO|PROPRIETARY TRADING
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors.    
CORPORATE OFFICE
address
  • 9/2003-4,
  • Vishnu Priya Limda Chowk
  • Main Road
  • Surat – 395 003.
fax us @ +91-261-6673537
email us @ info@rwadiwala.com

Feed Back  | Terms & Conditions  | SEBI  | FMC  | NSE  | BSE  | MCX  | NCDEX  | IRDA  |  AMFI  | Disclaimer  | Privacy Policy  | Careers | User Agreements  | Ethics Policy  | Investor Protection  |  Dos and Don'ts   |  Rights and Obligations   |  Uniform Risk Disclosure   |   Important Policies   |  To File A Complaint on SCORES   | Sitemap 

SEBI Regn No. BSE - CM/F&O, NSE - CM/F&O/CDS: INZ000187332 | SEBI PMS regn no.: INP000004045 | MCX & NCDEX SEBI Regn No.: INZ000080636 | CDSL DP ID: 12043100
| R Wadiwala Securities Pvt Ltd - CIN: U67120GJ2004PTC044324 | R Wadiwala Commodities Pvt Ltd - CIN: U51109GJ2007PTC050176

Compliance Officer - Email ID: compliance@rwadiwala.com | Contact No.: 0261-6673542

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by us, our employees, and our servants.

Investor Greivance Redressal at support@rwadiwala.com

Copyright © 2016 | All Rights Reserved. R.Wadiwala group.

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.